These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15516020)

  • 1. Regulatory evaluation of efficacy and safety of new drugs in Thailand.
    Hutangkabodee S; Krisanaphan C; Reggi V; Figueras A; Bonati M
    J Med Assoc Thai; 2004 Sep; 87(9):1135-6. PubMed ID: 15516020
    [No Abstract]   [Full Text] [Related]  

  • 2. The pediatric research equity act and oncology.
    Hirschfeld S
    Pediatr Blood Cancer; 2004 Aug; 43(2):99-102. PubMed ID: 15236272
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug evaluation: new requirements and perspectives].
    Addis A; Rocchi F
    Recenti Prog Med; 2006 Nov; 97(11):618-25. PubMed ID: 17252718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomeric drug development: issues, considerations, and regulatory requirements.
    Srinivas NR; Barbhaiya RH; Midha KK
    J Pharm Sci; 2001 Sep; 90(9):1205-15. PubMed ID: 11745774
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory evaluation of efficacy and safety of new drugs in China.
    Zhang XL; Reggi V; Bertele V; Bonati M
    Chin Med J (Engl); 2004 Feb; 117(2):320. PubMed ID: 15025134
    [No Abstract]   [Full Text] [Related]  

  • 6. Special section. The evaluation of drugs: an international perspective.
    Int J Technol Assess Health Care; 1986; 2(4):613-708. PubMed ID: 10280881
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences in approving drugs].
    Schnieders B
    Internist (Berl); 1980 Jun; 21(6):325-32. PubMed ID: 7005169
    [No Abstract]   [Full Text] [Related]  

  • 8. Can Health Canada protect Canadians from unsafe drugs?
    Hébert PC; Stanbrook MB; MacDonald N; Flegel K; Coutts J; MacLeod S
    CMAJ; 2011 Jul; 183(10):1125-6. PubMed ID: 21502342
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for the procurement of investigational and emergency drugs.
    Madsen M
    Can J Hosp Pharm; 1988 Oct; 41(5):275-6. PubMed ID: 10290647
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability evaluation of vaccines.
    Schofield T; Krause PR
    Biologicals; 2009 Nov; 37(6):355. PubMed ID: 19783158
    [No Abstract]   [Full Text] [Related]  

  • 11. Thai War on Drugs: measuring changes in methamphetamine and other substance use by school students through matched cross sectional surveys.
    Daosodsai P; Bellis MA; Hughes K; Hughes S; Daosodsai S; Syed Q
    Addict Behav; 2007 Aug; 32(8):1733-9. PubMed ID: 17223280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs.
    Powers JH
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S153-62. PubMed ID: 17683020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new era in drug regulation?
    Dresser R
    Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigational new drugs: export requirements for unapproved new drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Nov; 70(225):70720-30. PubMed ID: 16304736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The National Board of Health and Welfare's new guidellines on drug handling. Let the delegation of drug handling be the responsibility of the acting heads].
    Hallum U
    Lakartidningen; 2000 Jun; 97(24):3000. PubMed ID: 10900887
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug safety and drug efficacy: two sides of the same coin.
    Young RC; Friedman MA; Schilsky RL; Sigal EV
    Clin Cancer Res; 2007 May; 13(9):2533-4. PubMed ID: 17473179
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs used in pregnancy: the regulatory process.
    Tomalin A
    Can J Clin Pharmacol; 2007; 14(1):e5-9. PubMed ID: 17213510
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing abuse liability during drug development: changing standards and expectations.
    Schoedel KA; Sellers EM
    Clin Pharmacol Ther; 2008 Apr; 83(4):622-6. PubMed ID: 18212799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory challenges for new formulations of controlled substances in today's environment.
    McCormick CG
    Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S63-7. PubMed ID: 16567060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.